AMRX AMNEAL PHARMACEUTICALS INC Earnings Reports 8-K Filing 2023 - Reaffirmation of Financial Guidance Amneal Pharmaceuticals reaffirms its previously issued financial guidance for the year 2022, including net revenue of $2.15 billion - $2.25 billion and adjusted EBITDA of $500 million - $520 million.Get access to all SEC 8-K filings of the AMNEAL PHARMACEUTICALS INC